Hepatitis Monthly
Official Journal of Research Center for Gastroenterology and Liver Diseases
Outlines
European vs. Egyptian HCV-4 Patients with Elevated Baseline HCV RNA, Treated with PEG-IFN-α2a and Ribavirin: The Role of Rapid and Early Virologic Response
Dimitrios Dimitroulopoulos1,*, Ioannis Elefsiniotis2, Christos Pavlidis3, Dimitrios Xinopoulos1, Klisthenis Tsamakidis1, Stamatina Patsavela1, Dimitrios Kypreos1, Ageliki Ferderigou4, Dimitrios Korkolis5, Sotirios Koutsounas6, Georgios Saroglou7, Emmanouil Paraskevas8References
- 1.The references are available in the PDF file.
Copyright
© 2010, Author(s). This open-access article is available under the Creative Commons Attribution 4.0 (CC BY 4.0) International License (https://creativecommons.org/licenses/by/4.0/), which allows for unrestricted use, distribution, and reproduction in any medium, provided that the original work is properly cited.
Similar Articles
Efficacy of 24-Week Pegylated Interferon Alpha and Ribavirin Combination Therapy in Highly Selected Patients Infected With Hepatitis C Virus Genotype 1
Sharafi H, Alavian SM, Keshvari M. Efficacy of 24-Week Pegylated Interferon Alpha and Ribavirin Combination Therapy in Highly Selected Patients Infected With Hepatitis C Virus Genotype 1. Hepat Mon. 2015;15(1):e24955. doi: https://doi.org/10.5812/hepatmon.24955
Optimizing Treatment with Pegylated Interferon-Ribavirin of Genotype 3 Chronic Hepatitis C: More Questions than Answers
Aghemo A, D'Ambrosio R, Rumi M, Colombo M. Optimizing Treatment with Pegylated Interferon-Ribavirin of Genotype 3 Chronic Hepatitis C: More Questions than Answers. Hepat Mon. 2008;8(4):. doi:
Consensus Interferon Plus Ribavirin for Hepatitis C Genotype 3 Patients Previously Treated With Pegylated Interferon Plus Ribavirin
Abbas Z, Tayyab GN, Qureshi M, Memon MS, Subhan A, et al. Consensus Interferon Plus Ribavirin for Hepatitis C Genotype 3 Patients Previously Treated With Pegylated Interferon Plus Ribavirin. Hepat Mon. 2013;13(12):e14146. doi: https://doi.org/10.5812/hepatmon.14146
The Effect of Peginterferon Alpha-2a vs. Peginterferon Alpha-2b in Treatment of Naive Chronic HCV Genotype-4 Patients: A Single Centre Egyptian Study
El Raziky M, Fathalah WF, El-akel WA, Salama A, Esmat G, et al. The Effect of Peginterferon Alpha-2a vs. Peginterferon Alpha-2b in Treatment of Naive Chronic HCV Genotype-4 Patients: A Single Centre Egyptian Study. Hepat Mon. 2013;13(5):10069. doi: https://doi.org/10.5812/hepatmon.10069
Rapid Virological Response Represents the Highest Prediction Factor of Response to Antiviral Treatment in HCV-Related Chronic Hepatitis: a Multicenter Retrospective Study
Federico A, Masarone M, Romano M, Dallio M, Rosato V, et al. Rapid Virological Response Represents the Highest Prediction Factor of Response to Antiviral Treatment in HCV-Related Chronic Hepatitis: a Multicenter Retrospective Study. Hepat Mon. 2015;15(6):e18640. doi: https://doi.org/10.5812/hepatmon.15(6)2015.18640
- Scopus by DOI: 0
Last Update: 1 week ago
- Scopus by Title: 8
Last Update: 1 week ago
- Scopus by Title (Ref): 8
Last Update: 1 week ago
- CrossRef: 0
Last Update: 4 days ago
Ordering Reprints
Articles are published under the Creative Commons license stated on each article. No permission or royalty fee is required for uses permitted by that license. CCC handles optional bulk and customized reprint orders. Any quotation covers production and delivery services only, not copyright permission. > Request Reprints from CCC
Author(s):
- Dimitrios Dimitroulopoulos:[PubMed][Scholar]
- Ioannis Elefsiniotis:[PubMed][Scholar]
- Christos Pavlidis:[PubMed][Scholar]
- Dimitrios Xinopoulos:[PubMed][Scholar]
- Klisthenis Tsamakidis:[PubMed][Scholar]
- Stamatina Patsavela:[PubMed][Scholar]
- Dimitrios Kypreos:[PubMed][Scholar]
- Ageliki Ferderigou:[PubMed][Scholar]
- Dimitrios Korkolis:[PubMed][Scholar]
- Sotirios Koutsounas:[PubMed][Scholar]
- Georgios Saroglou:[PubMed][Scholar]
- Emmanouil Paraskevas:[PubMed][Scholar]